Changchun Bcht Biotechnology Co.
Clinical trials sponsored by Changchun Bcht Biotechnology Co., explained in plain language.
-
First human test for new Triple-Threat booster shot
⭐️ VACCINE ⭐️ Not yet recruitingThis is an early-stage study to check the safety and immune response of a new combined vaccine for adolescents and adults. The vaccine aims to protect against whooping cough (pertussis), diphtheria, and tetanus. Researchers will give different doses to 96 healthy volunteers aged …
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:37 UTC
-
First human test for Next-Gen flu shot begins
⭐️ VACCINE ⭐️ Not yet recruitingThis is an early-stage study to check if a new flu vaccine, which includes a special ingredient called BK-01 adjuvant, is safe and can trigger a good immune response in healthy adults. Researchers will give the vaccine to 160 people and closely monitor them for any side effects f…
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 17, 2026 13:09 UTC